Start-Up Claims to Treat a Patient With A.I.-Created Viruses

A groundbreaking start-up has reportedly used artificial intelligence to design a virus that targets and clears antibiotic-resistant bacterial infections in a patient. This innovative approach leverages bacteriophages, viruses that specifically attack harmful bacteria, offering a potential new treatment method against infections that traditional antibiotics can't tackle. The implications of this development could be significant in the fight against antibiotic resistance, a major global health concern. For more details, you might want to check out the full article in The New York Times.